Tender offer | Stunning results | Big second half
A medical device company covered here continues to generate plenty of cash and is committing to another significant tender offer. Elsewhere, a supplier of colour cosmetics is banking on a very big second half to meet forecasts, while there is still little love for a provider of veterinary services. Read on here for our thoughts on this and other news, including our assessment of results from a fast-growing provider of floor coverings!
Warpaint London: big second half needed Interim results from Warpaint London (AIM: W7L), the supplier of affordable colour cosmetics and personal care brands suggests a very big second half is needed to meet full year forecasts, despite the latter being revised down. For the six months to the end of June 2026 revenue fell 17.8% to £40.5m while statutory pre-tax profit was 33% lower at only £4.9m. Cash flow was much better with a net operating cash inflow of £7.4m and free cash inflow of £4.7m lifting period end cash to £20.7m, equivalent to approx. 26 pence per share or…